SciVision Biotech (Taiwan) Probability of Future Stock Price Finishing Under 109.84
| 1786 Stock | TWD 94.70 0.40 0.42% |
SciVision |
SciVision Biotech Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of SciVision Biotech for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for SciVision Biotech can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| SciVision Biotech generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are owned by insiders or employees |
SciVision Biotech Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of SciVision Stock often depends not only on the future outlook of the current and potential SciVision Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. SciVision Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 66.2 M |
SciVision Biotech Technical Analysis
SciVision Biotech's future price can be derived by breaking down and analyzing its technical indicators over time. SciVision Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of SciVision Biotech. In general, you should focus on analyzing SciVision Stock price patterns and their correlations with different microeconomic environments and drivers.
SciVision Biotech Predictive Forecast Models
SciVision Biotech's time-series forecasting models is one of many SciVision Biotech's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary SciVision Biotech's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about SciVision Biotech
Checking the ongoing alerts about SciVision Biotech for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for SciVision Biotech help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| SciVision Biotech generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are owned by insiders or employees |
Additional Tools for SciVision Stock Analysis
When running SciVision Biotech's price analysis, check to measure SciVision Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SciVision Biotech is operating at the current time. Most of SciVision Biotech's value examination focuses on studying past and present price action to predict the probability of SciVision Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SciVision Biotech's price. Additionally, you may evaluate how the addition of SciVision Biotech to your portfolios can decrease your overall portfolio volatility.